Nectin Therapeutics raises $25 million Series A to treat advanced cancer tumors - aMoon

WE believe
portfolio
alpha
TEAM
IMPACT
news & INSIGHTS

Nectin Therapeutics raises $25 million Series A to treat advanced cancer tumors

Nectin Therapeutics raises $25 million Series A to treat advanced cancer tumors

Nectin Therapeutics raises $25 million Series A to treat advanced cancer tumors

Contact Careers terms of service privacy policy

Ra'anana, Israel

© 2021 aMoon Website by nym. Developed by Rabbi Interactive